Page last updated: 2024-11-04

vorinostat and Irritable Bowel Syndrome

vorinostat has been researched along with Irritable Bowel Syndrome in 1 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Moloney, RD1
Stilling, RM1
Dinan, TG1
Cryan, JF1

Other Studies

1 other study available for vorinostat and Irritable Bowel Syndrome

ArticleYear
Early-life stress-induced visceral hypersensitivity and anxiety behavior is reversed by histone deacetylase inhibition.
    Neurogastroenterology and motility, 2015, Volume: 27, Issue:12

    Topics: Animals; Anxiety; Blotting, Western; Disease Models, Animal; Female; Histone Deacetylase Inhibitors;

2015